vTv Therapeutics: Millennium Group reports 5.0% stake

Rhea-AI Filing Summary

vTv Therapeutics Inc. Schedule 13G reports that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander together disclose shared voting and dispositive power over 198,237 shares of Class A Common Stock, representing 5.0% of the class as shown on the cover page dated 03/24/2026.

The filing states these shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers, and includes a Joint Filing Agreement dated 03/26/2026.

Insights

Institutional Ownership Analyst

A passive disclosure of a roughly 5.0% position by Millennium-related entities.

The Schedule 13G lists shared voting and dispositive power of 198,237 shares representing 5.0% of vTv Therapeutics Class A common stock as of 03/24/2026. The filing is presented under joint filing signatures and includes an exhibit: a Joint Filing Agreement dated 03/26/2026.

Because the statement ties ownership to entities under Millennium's control, subsequent trading or disclosures by these entities could change the position; future Form 13D/13G amendments would reflect material shifts.

Corporate Governance Specialist

Filing clarifies voting/dispositive arrangement but disclaims automatic admission of beneficial ownership.

The filing explicitly states the securities are "held by entities subject to voting control and investment discretion" by Millennium and related managers, and cautions against construing that language as an admission of beneficial ownership.

Investors seeking governance implications should note the shared voting power label and the joint-filing structure; any coordination or changes would be disclosed in later filings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake did Millennium report in vTv Therapeutics (VTVT)?

Millennium-related filers reported shared voting and dispositive power over 198,237 shares, equal to 5.0% of Class A Common Stock. The cover page shows the position tied to the filing date 03/24/2026.

Who filed the Schedule 13G for VTVT?

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed the Schedule 13G and executed a Joint Filing Agreement dated 03/26/2026 as shown in the exhibit.

Does the filing say Millennium beneficially owns the reported shares?

The filing states the shares are held by entities subject to voting control and investment discretion by Millennium and related managers, and explicitly cautions that this should not be construed as an admission of beneficial ownership.

What voting power is disclosed in the VTVT filing?

The Schedule 13G discloses shared voting power of 198,237 shares and shared dispositive power of 198,237 shares, both labeled on the cover page and tied to the reported 03/24/2026.

When was the Schedule 13G signed for VTVT?

Signatures on the filing are dated 03/26/2026, including a signature by Israel A. Englander and by Gil Raviv as Global General Counsel for Millennium entities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:45 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

vTv Therapeutics Inc.

(Name of Issuer)

Class A Common Stock, par value $0.01 per share

(Title of Class of Securities)

918385204

(CUSIP Number)

03/24/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 198,237.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 198,237.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

198,237.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 198,237.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 198,237.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

198,237.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 198,237.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 198,237.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

198,237.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: vTv Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 3980 Premier Drive, Suite 110, High Point, North Carolina 27265
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Class A Common Stock, par value $0.01 per share
(e)	CUSIP Number(s): 918385204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit I
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	03/26/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	03/26/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	03/26/2026

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of March 26, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.